Africa CDC is pumping the brakes on Congo Ebola optimism. Hard. For anyone joining us mid-arc, here's the short version: the DRC Bundibugyo outbreak has moved unevenly. MSF said transmission was slowing in Ituri, but cases were showing up in underprepared areas. South Ubangi had become the seventh affected province, and North Kivu was accounting for a large share of newly confirmed cases. Basic response measures have remained inconsistent between the original hotspots and newer affected areas. This is Ebola Watch. Today: who's calling progress too soon—and what may have been missed at the start. From Nsem360:
The Ebola outbreak in the Democratic Republic of Congo remains a serious public health concern, with data pointing to persistent gaps in infection prevention and control measures, Africa’s leading public health agency has warned. Although Congo’s Health Minister Samuel Roger Kamba reported “encouraging signs” in the country’s response, saying transmission had been gradually declining since a peak in mid-August, the Africa Centres for Disease Control and Prevention (Africa CDC) said the outbreak had not yet been brought under control.
Congo's health minister says cases have been declining since mid-August. Africa CDC's Jean Kaseya says the last two weeks of data are too modest and too uneven to call a peak. Those are very different messages for people living with this outbreak. On the DRC Bundibugyo outbreak, Africa CDC says the decline is too uneven to call a peak. Ituri is seeing fewer infections, but its Emergency Consultative Group says transmission remains inconsistent across affected areas. So, “encouraging” is fair. “Under control” isn't. Kaseya wants to see a sustained reduction before anyone declares victory. And that matters in practice: infection-prevention gaps can keep an outbreak alive even while one province's curve bends downward. From World Health Organization:
Nonetheless, this epidemic remains a public health emergency of international concern. It is unfolding in a context of insecurity, displacement, and a fragile health system. There is still active transmission in multiple affected locations, and the risk of further spread remains real. The response will need to be sustained and strengthened over many months.
WHO's Tedros is holding two facts together: transmission in Ituri is declining, and this remains a public health emergency of international concern. More than 1,700 recoveries matter, but active transmission across multiple locations still sets the operational agenda. And after that Africa CDC warning, the “encouraging signs” language hits differently. The Congolese health minister sees improvement; Africa CDC says it hasn't peaked; WHO says the emergency designation stays in place and this needs funding for months. WHO credits improved contact tracing and treatment capacity, along with stronger community engagement. It also points to the gaps: insecurity, displacement, a fragile health system, and a real risk of further spread. Nobody at WHO is taking a victory lap. And the funding appeal isn't ceremonial language. If WHO says the response must be sustained and strengthened over many months, a short burst of donor attention doesn't match the outbreak they're describing. Here's Medair:
BUNIA, Democratic Republic of the Congo, 16. September — The Ebola outbreak spreading across the Democratic Republic of the Congo (DR Congo) could become the deadliest ever recorded if it continues at its current pace, according to the World Health Organization (WHO), as humanitarian organisation Medair scales up its emergency health response.
Medair's benchmark is grim: 3,475 deaths by September 12, and WHO says this could pass the West Africa epidemic—the one that killed more than 11,000 people. This has moved past an abstract warning. And Medair reports 514 cases and 249 deaths in the week from September 6 through 12. Those are confirmed-case figures. Nearly one in two confirmed patients is dying, an emergency moving far faster than the response can safely absorb. Medair is scaling up in Ituri and North Kivu while people are still dying before they can reach designated treatment centres. A treatment centre can be excellent; it can't treat somebody who never makes it through the door. Africa CDC won't call a peak. Medair's pace data tell you why: six provinces, more than 90 new cases a day by mid-August, and transmission still uneven across the map. Ogechi Ekeanyanwu, writing in Eurasia Review:
CEPI is putting up to $8.5 million into Hilleman Labs (MSD–Wellcome, Singapore) for an rVSV Bundibugyo candidate from IAVI that WHO called most promising. Primate data exist; first trial-ready lots are aimed at year-end. Plant upgrades from a separate $30 million Ervebo grant are meant to cut cost and allow fridge storage.
Wait—the 70,000 Ervebo doses going to DRC aren't a Bundibugyo vaccine campaign. Eurasia Review says 50,000 are for health workers, and 20,000 are being used in a cross-protection trial. Correct. Ervebo is licensed against Zaire Ebola, while Bundibugyo is driving this outbreak. Giving it to frontline staff may still generate evidence, but it isn't established protection. And the most promising strain-specific candidate is still in the future: CEPI's up-to-$8.5-million rVSV project with Hilleman Labs and IAVI is aiming for trial-ready lots by year-end. More than 3,000 people have already died. That's the operational gap. WHO has called this outbreak faster-growing than any previous Ebola outbreak; a candidate still awaiting its first trial lots can't protect a nurse in Ituri today. Deutsche Welle, with Jean-Michel Bos:
According to their data, the first known case, identified retrospectively, was a health worker from Mongbwalu in northeastern Ituri Province. The person, sources said, developed symptoms characteristic of Ebola around April 24 or 25. They died at a medical center in Bunia, the capital of Ituri. To date, 80% of all cases have been reported in the province.
DW puts the first known case on the map: Mongbwalu, Ituri. A health worker developed symptoms around April 24 or 25, then died in Bunia—and the official declaration came May 15. We're looking at a surveillance gap of weeks, possibly longer. DW says the outbreak may have circulated months earlier. The start date is still under debate, but everyone agrees detection came late. And 80% of reported cases are now in Ituri. You can't prove every later infection traces back to that missed window, but it explains why “how did this get so large?” has such an uncomfortably concrete answer. Africa CDC won't call a peak, and this timeline makes clear why: a response can only get ahead of transmission it's actually found—and people were dying before the system recognized the pattern. If your team needs a daily briefing on your own industry, competitors, market, or beat, Lantern can make a private version like this for your whole team. Learn more at lantern podcasts dot com slash briefings, with a 14-day free trial.
Looking ahead, Hilleman Labs' first trial-ready lots for the rVSV Bundibugyo vaccine candidate are aimed at year-end. Links to every story are in the show notes, so take a look at the ones you'd like to explore further. Thanks for listening, and we'll be back next episode. That's Ebola Watch for today. This is a Lantern Podcast.